首页> 外文期刊>The Clinical neuropsychologist >Assessing reliable change using the repeatable battery for the assessment of neuropsychological status (RBANS) for patients with parkinson's disease undergoing Deep Brain Stimulation (DBS) surgery
【24h】

Assessing reliable change using the repeatable battery for the assessment of neuropsychological status (RBANS) for patients with parkinson's disease undergoing Deep Brain Stimulation (DBS) surgery

机译:使用可重复使用的电池评估帕金森病患者接受深部脑刺激(DBS)手术的神经心理状态(RBANS)的可靠变化

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Parkinson's disease (PD) is progressive neurological disease characterized by resting tremor, rigidity, akinesia, postural instability and cognitive changes. The symptoms of PD are debilitating and often become unsatisfactorily treated by medication. Deep brain stimulation (DBS) is an effective treatment to significantly reduce the cardinal motor symptoms of PD. However, the neuropsychological effects of this treatment are less clear. This study examined pre-to post-DBS scores on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) using Reliable Change Indices (RCIs) derived from 20 patients with PD who were medically managed, and then compared to 20 patients with PD treated with DBS and medication. When using group statistical analyses and false discovery rate correction, no significant differences between or within groups were evident at baseline or at follow-up. However, when using the RCIs more patients in the DBS group exhibited reliable change in RBANS scores than did the Med Tx group. Although preliminary, these RCIs provide clinicians and researchers a foundational tool for assessing the effects of interventions (e.g., DBS) independent of the effects of PD and measurement error when using the RBANS.
机译:帕金森氏病(PD)是进行性神经系统疾病,其特征在于静息性震颤,僵硬,运动障碍,姿势不稳和认知变化。 PD的症状使人衰弱,并且常常不能通过药物治疗。深部脑刺激(DBS)是一种有效的治疗方法,可大大减轻PD的主要运动症状。但是,这种治疗的神经心理学作用尚不清楚。这项研究使用来自20名接受过PD治疗的PD患者的可靠变化指数(RCI),在可重复电池评估神经心理状态(RBANS)的DBS评分之前进行了研究,然后与20例接受PD治疗的患者进行了比较DBS和药物治疗。当使用组统计分析和错误发现率校正时,在基线或随访时,组之间或组内没有明显差异。但是,使用RCI时,与Med Tx组相比,DBS组中更多的患者表现出可靠的RBANS评分变化。这些RCI虽是初步的,但为临床医生和研究人员提供了一种基础工具,可用于评估干预措施(例如DBS)的效果,而与使用RBANS时PD的影响和测量误差无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号